Trial Profile
Clinical Trials Insight: 700055146
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Apr 2010
Price :
$35
*
At a glance
- Drugs Tucidinostat (Primary) ; Antineoplastics
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Chipscreen Biosciences; HUYA Bioscience International
- 06 Apr 2010 New trial record.